Navigation Links
SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS

MUMBAI, India, Feb. 9 /PRNewswire/ -- SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.  

DreamCIS has nearly a decade of experience in offering clinical research services to pharmaceutical companies, bio venture companies, medical device manufacturers, and functional food producers. Their services includes Clinical Trial Management, Pharmacovigilance, Post Marketing Surveillance (PMS), Data Management, Biostatistics and Quality Assurance services.

SIRO Clinpharm has been in the arena of contract clinical research for more than 14 years, conducting ICH GCP compliant clinical trials for its global clientele. In addition to the services that DreamCIS provides, SIRO's service list also includes Medical Writing, Clinical Trials Supplies Management, Feasibility and Patient Planning.

"This pact will help us on one hand to build a strong competitive advantage in the Asia Pacific region, while on the other hand it will create a sustainable value for our existing as well as potential customers," said Ajit Nair, Ph.D., President, India. He further added that, "Our goal is to offer a wider platform of patient recruitment capabilities from the Asia Pac region for our global client base."

"We are one of the leading and fastest growing CROs in South Korea. However, looking at the increasing number of global clinical trials and the rapid growth in the Asian clinical trials market, we were looking at associating ourselves with a CRO having a global exposure; not only from business vertical perspective but also from the perspective of moving up on the learning curve. I think our mutually beneficial alliance with SIRO is a definite step in this direction," said Won-Jung Choi, President, DreamCIS Inc.    

"Korea is a rapidly growing clinical trials market due to various advantages it offers like pre-approved and well-equipped clinical trial sites, trained professionals, and transparent and efficient regulatory processes," said Chetan Tamhankar, PhD, SIRO's Chief Executive Officer. "We are confident this alliance will be of immense value to SIRO and widen our global service capabilities."

About SIRO:

SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors in compliance with international standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, the USA, Israel and in Europe in Germany, Romania, Estonia, Greece, Czech Republic and Spain.

For more information please visit -

About DreamCIS:

Founded in April, 2000, DreamCIS has been dedicated to providing a full range of clinical services for pharmaceutical companies, bio venture companies medical device manufacturers and functional food producers in Korea. The company has also undertaken projects for some of the top global pharmaceutical companies in a broad range of therapeutic areas in accordance with ICH GCP guidelines.

For more information please visit –




Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
2. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
3. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
4. SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
5. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
6. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
7. Zassi Medical Evolutions Spins out Electrical Stimulation Technology for Gastrointestinal Continence Control and Forms New Company with Technology Investment Firm
8. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
9. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
10. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
11. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
Post Your Comments:
(Date:12/1/2015)... , Dec. 01, 2015 ... the addition of the "Medium Molecular ... Sealants, Lubricants, and Other Applications - Global ... Forecast, 2015 - 2023" report to ... has announced the addition of the ...
(Date:12/1/2015)... --  Nottingham Spirk , a leading consumer and ... a free whitepaper , "The Executive,s Guide ... gives medical product companies, pharmaceutical manufacturers and others ... Nottingham Spirk survey shows consumers ... health, save money (i.e., fewer doctors, visits), address ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 /PRNewswire/ ... ) today announced that its Chief Executive ... at the Oppenheimer Annual Healthcare Conference in ... participate in the conference through a webcast ... , --> ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... independence is everything. That is why Hollister Incorporated has launched the VaPro Plus ... this next product in the VaPro touch free catheter portfolio,” said Michael Gresavage, ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... announced it has been awarded a fixed price per sprint agile development contract ... valued at $34 million over five years, provides software engineering, infrastructure, as well ...
(Date:12/1/2015)... ... December 01, 2015 , ... TCS ... care management and population health arenas, is pleased to announce that VIP Care ... services, has successfully implemented the ACUITY Complete Care™ Management to back their collaborative ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - ... to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, ... Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist ...
Breaking Medicine News(10 mins):